Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines.

MLA

Tost, Jörg, et al. “Methylation of Specific CpG Sites in the P2 Promoter of Parathyroid Hormone-Related Protein Determines the Invasive Potential of Breast Cancer Cell Lines.” Epigenetics, vol. 6, no. 8, Aug. 2011, pp. 1035–46. EBSCOhost, https://doi.org/10.4161/epi.6.8.16077.

APA

Tost, J., Hamzaoui, H., Busato, F., Neyret, A., Mourah, S., Dupont, J.-M., & Bouizar, Z. (2011). Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines. Epigenetics, 6(8), 1035–1046. https://doi.org/10.4161/epi.6.8.16077

Chicago

Tost, Jörg, Hinda Hamzaoui, Florence Busato, Aymeric Neyret, Samia Mourah, Jean-Michel Dupont, and Zhor Bouizar. 2011. “Methylation of Specific CpG Sites in the P2 Promoter of Parathyroid Hormone-Related Protein Determines the Invasive Potential of Breast Cancer Cell Lines.” Epigenetics 6 (8): 1035–46. doi:10.4161/epi.6.8.16077.